Injectable Vitamin D3 Recalled Over Sterility Concerns at Manufacturing Facility
Pharmacy Innovations recalls Cholecalciferol (Vitamin D3) 100,000U/ML Injectable nationwide due to insanitary conditions at the manufacturing facility that compromise product sterility assurance.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard—insanitary facility conditions affecting a sterile injectable product—represents a contamination risk without confirmed harm, placing this at High severity.
Plain-English summary
Pharmacy Innovations, located in Erie, Pennsylvania, has recalled Cholecalciferol (Vitamin D3) 100,000U/ML Injectable nationwide. The recall was initiated after FDA inspection revealed insanitary conditions at the manufacturing facility.
The product is an injectable vitamin D3 supplement available only by prescription. Because it is an injectable preparation, any compromise to sterility assurance poses a potential health risk. The insanitary conditions found during FDA inspection raise concerns that the manufacturing environment may not meet required standards for producing sterile injectable pharmaceuticals.
Patients currently using this product should consult their healthcare provider immediately. Do not stop taking your medication without medical guidance. Your healthcare provider can advise whether this product should be discontinued or replaced with an alternative source of vitamin D supplementation.
Healthcare providers and pharmacies should quarantine all affected inventory and return it to the manufacturer according to the recall instructions.
The recalled product
- Product
- Cholecalciferol (Vitamin D3) 100,000U/ML Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
- Manufacturer
- Pharmacy Innovations
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t20221130@14
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 59 recalled by Pharmacy Innovations under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 59 products in this recall →Related recalls
Same manufacturer · Pharmacy Innovations
See all →- HighEdetate Disodium Ophthalmic Solution Recalled for Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighInjectable Hydroxocobalamin Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- HighFDA Recalls Acetylcysteine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighMethylcobalamin Injectable Recall Due to Facility Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- HighInjectable vitamin B-complex products recalled for lack of sterility assurance
FDA (Drugs) · 2023-02-01
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24